Trial · NCT07893496
Efficacy and Safety of Ultrasound-Guided Pharmacopuncture as an Adjunctive Therapy in Inpatients With Post-Traffic Accident Tension-Type Headache
NCT07893496, Not applicable, Recruiting, Jaseng Medical Foundation
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Efficacy and Safety of Ultrasound-Guided Pharmacopuncture as an Adjunctive Therapy in Inpatients With Post-Traffic Accident Tension-Type Headache. Trials, record NCT07893496. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07893496
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Efficacy and Safety of Ultrasound-Guided Pharmacopuncture as an Adjunctive Therapy in Inpatients With Post-Traffic Accident Tension-Type Headache
- NCT number
- NCT07893496
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 40 participants, estimated
- Lead sponsor
- Jaseng Medical Foundation
- Conditions
- Pharmacologic Action
- Interventions
- Cervicocranial ultrasound-guided pharmacopuncture, Oriental medicine integrated treatment
- First posted
- 2026-10-26
- Last updated
- 2026-10-26
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Headache numeric rating scale (NRS) | through admission completion, an average of 2week, 4 weeks and 8 weeks after admission date | The intensity of Headache will be assessed using the NRS. In the NRS, participants choose a number from 0 to 10 that best describes participant's comfort (0 being no pain and 10 being the most comfortable they can imagine). |
| Secondary | Neck pain numeric rating scale (NRS) | through admission completion, an average of 2week, 4 weeks and 8 weeks after admission date | The intensity of Neck pain will be assessed using the NRS. In the NRS, participants choose a number from 0 to 10 that best describes participant's comfort (0 being no pain and 10 being the most comfortable they can imagine). |
| Secondary | Headache Disability Index (HDI) | through admission completion, an average of 2week, 4 weeks and 8 weeks after admission date | The physical and emotional disability experienced by participants due to headache will be assessed to evaluate changes before and after treatment. It consists of a total of 25 items, with each item following the standardized scoring method of the original questionnaire tool (Yes = 4 points, Sometimes = 2 points, No = 0 points). The total score obtained through the survey reflects the degree of daily life restriction and quality of life due to headache, with higher scores indicating a greater degree of disability. |
| Secondary | Headache Impact Test (HIT-6) | through admission completion, an average of 2week, 4 weeks and 8 weeks after admission date | The functional status and impact of headache on daily life will be assessed using the Headache Impact Test-6 (HIT-6). The HIT-6 is a 6-item questionnaire, with each item scored on a 5-point scale (Never = 6, Rarely = 8, Sometimes = 10, Very often = 11, Always = 13). The total score ranges from 36 to 78, where 36 indicates little to no impact and 78 indicates severe impact. A higher score indicates a worse outcome (greater headache severity and functional disability). |
| Secondary | EuroQol-5 Dimension (EQ-5D-5L) | Enrollment date, 2, 4 and 8 weeks after admission date | EQ-5D-5L is a method of evaluating health status from various aspects and then indirectly calculating the quality weight of a specific health status using pre-assigned preference scores for each functional level. It is the most widely used among several indirect measurement methods. there is. The EQ-5D-5L consists of 5 questions. Each question includes mobility, self-care, usual activities, pain/discomfort, and anxiety/depression ( Ask about the level of anxiety/depression, etc. Weights are assigned according to the level of each item, and the preference score calculation equation is presented based on these weights and constants. |
| Secondary | Patient Global Impression of Change (PGIC) | 8days, 2, 4, 8 weeks after admission date | This is a method that allows participants to subjectively evaluate the degree of improvement on a 7-level scale: 1, very much improved; 2, much improved; 3, minimally improved; 4, no change; 5, minimally worse; 6, much worse; or 7, very much worse. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07893496
GET https://conductscience.org/api/trials/v1/NCT07893496/registered